Probably Tribe on creep to get his average down - it always seems to go down after he puts money up.
Amgen & Takeda went with Feldan the other day hoping to get things in clinic by 2021.
Feldan already have GlaxoSmithKline, Janssen & Sanofi behind them.
Jun 5, 2019 11:04am
Amgen and Takeda have signed on to a Canadian research consortium to help develop a novel drug delivery technology that aims to help transport proteins directly into cells, with both ex vivo and in vivo applications.
The peptide-based project, spearheaded by Quebec-based Feldan Therapeutics, has demonstrated uses in a variety of cell types in animal models, as well as in organs such as the eyes, lungs and brain.
Dubbed the Feldan Shuttle, it has delivered active CRISPR nucleases, transcription factors, antibodies and enzymes—with the ultimate goal of providing a direct intracellular therapy route or the manufacture of cell-based treatments.
- Forums
- ASX - By Stock
- PYC
- Ann: March 2019 Quarterly Operational Update and App4C
PYC
pyc therapeutics limited
Add to My Watchlist
3.63%
!
$1.29

Ann: March 2019 Quarterly Operational Update and App4C, page-45
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M |
Open | High | Low | Value | Volume |
$1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 58344 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 1.230 |
1 | 20000 | 1.220 |
1 | 1500 | 1.200 |
1 | 8000 | 1.135 |
1 | 2000 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 58344 | 1 |
1.290 | 24500 | 1 |
1.300 | 8000 | 1 |
1.325 | 9001 | 1 |
1.330 | 10756 | 2 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |